Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
Holding BEAM?
Track your performance easily

Beam Therapeutics (BEAM) Financial Statements

1,279 Followers

Beam Therapeutics Financial Overview

Beam Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.76; its P/E ratio is -13.66; Beam Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-1.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 14.27M$ 11.77M$ 7.41M$ 316.19M$ 17.19M
Gross Profit$ 14.27M$ 11.77M$ 7.41M$ 316.19M$ 17.19M
EBIT$ -96.67M$ -91.01M$ -110.39M$ 132.86M$ -96.09M
EBITDA$ -91.19M$ -85.44M$ -104.95M$ 138.22M$ -90.90M
Net Income Common Stockholders$ -96.67M$ -91.05M$ -98.67M$ 142.80M$ -96.09M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 925.76M$ 1.01B$ 1.09B$ 435.89M$ 1.02B
Total Assets$ 1.17B$ 1.26B$ 1.36B$ 1.46B$ 1.29B
Total Debt$ 162.06M$ 165.24M$ 168.12M$ 172.69M$ 173.98M
Net Debt$ -763.69M$ -842.93M$ -926.43M$ -263.21M$ -841.48M
Total Liabilities$ 380.05M$ 407.17M$ 446.31M$ 478.38M$ 511.59M
Stockholders Equity$ 791.32M$ 833.70M$ 913.49M$ 981.33M$ 778.94M
Cash Flow-
Free Cash Flow$ -89.70M$ -84.97M$ -102.19M$ 131.48M$ -97.73M
Operating Cash Flow$ -88.13M$ -83.01M$ -99.75M$ 135.07M$ -89.78M
Investing Cash Flow$ 24.70M$ 87.49M$ -53.46M$ 98.10M$ -10.23M
Financing Cash Flow$ 1.26M$ 133.00K$ 2.90M$ 33.71M$ 36.78M
Currency in USD

Beam Therapeutics Earnings and Revenue History

Beam Therapeutics Debt to Assets

Beam Therapeutics Cash Flow

Beam Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis